Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats

被引：0
|
作者：
Shizuka Aritomi
Kazumi Niinuma
Tetsuya Ogawa
Tomoyuki Konda
Kosaku Nitta
机构：
[1] Ajinomoto Pharmaceuticals Co.,Research Center
[2] Ltd.,Department of Medicine, Kidney Center
[3] Tokyo Women’s Medical University,Department of Medicine, Medical Center East
[4] Tokyo Women’s Medical University,undefined
来源：
Clinical and Experimental Nephrology | 2013年 / 17卷
关键词：
Cilnidipine; Streptozotocin; Blood pressure; Proteinuria; Renoprotection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：41 / 50
页数：9
相关论文
共 50 条
  • [1] Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats
    Aritomi, Shizuka
    Niinuma, Kazumi
    Ogawa, Tetsuya
    Konda, Tomoyuki
    Nitta, Kosaku
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (01) : 41 - 50
  • [2] Cilnidipine additively inhibits the progression of renal impairment in diabetic rats when used in combination with an angiotensin II receptor blocker (ARB)
    Matsuura, K.
    Mori, Y.
    Aritomi, S.
    Niinuma, K.
    Konda, T.
    Itoh, Y.
    Yokoyama, J.
    Tajima, N.
    DIABETOLOGIA, 2010, 53
  • [3] ACCELERATED PROGRESSION OF DIABETIC NEPHROPATHY IN THE SPONTANEOUSLY HYPERTENSIVE STREPTOZOTOCIN DIABETIC RAT
    COOPER, ME
    ALLEN, TJ
    JERUMS, G
    DOYLE, AE
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1986, 13 (09) : 655 - 662
  • [4] Cardiac hypertrophy in diabetic spontaneously hypertensive rats: Role of angiotensin II?
    Black, MJ
    Briscoe, T
    Bertram, JF
    Jackson, B
    Johnston, CI
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (06) : 445 - 448
  • [5] Effects of angiotensin II receptor blockers on diabetic nephropathy
    Kalaitzidis, Rigas
    Bakris, George L.
    JOURNAL OF HYPERTENSION, 2009, 27 : S15 - S21
  • [6] Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy
    Shin-ichiro Masuda
    Kouichi Tamura
    Hiromichi Wakui
    Tomohiko Kanaoka
    Masato Ohsawa
    Akinobu Maeda
    Toru Dejima
    Mai Yanagi
    Koichi Azuma
    Satoshi Umemura
    Hypertension Research, 2009, 32 : 950 - 955
  • [7] Effects of Angiotensin II Type 1 Receptor Blocker on Ambulatory Blood Pressure Profile in Hypertensive Patients with Overt Diabetic Nephropathy
    Tamura, Kouichi
    Wakui, Hiromichi
    Masuda, Shin-ichiro
    Kanaoka, Tomohiko
    Ohsawa, Masato
    Maeda, Akinobu
    Dejima, Toru
    Yanagi, Mai
    Shigenaga, Atsu-ichiro
    Azuma, Koichi
    Mitsuhashi, Hiroshi
    Yoshida, Shin-ichiro
    Okano, Yasuko
    Ishigami, Tomoaki
    Toya, Yoshiyuki
    Umemura, Satoshi
    HYPERTENSION, 2009, 54 (04) : E89 - E89
  • [8] Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy
    Masuda, Shin-ichiro
    Tamura, Kouichi
    Wakui, Hiromichi
    Kanaoka, Tomohiko
    Ohsawa, Masato
    Maeda, Akinobu
    Dejima, Toru
    Yanagi, Mai
    Azuma, Koichi
    Umemura, Satoshi
    HYPERTENSION RESEARCH, 2009, 32 (11) : 950 - 955
  • [9] Additive hypotensive and anti-albuminuric effects of angiotensin-converting enzyme inhibition and angiotensin receptor antagonism in diabetic spontaneously hypertensive rats
    Cao, ZM
    Bonnet, F
    Davis, B
    Allen, TJ
    Cooper, ME
    CLINICAL SCIENCE, 2001, 100 (06) : 591 - 599
  • [10] Effects of candesartan, an angiotensin II receptor type I blocker, on atrial remodeling in spontaneously hypertensive rats
    Choisy, Stephanie C.
    Kim, Shang-Jin
    Hancox, Jules C.
    Jones, Sandra A.
    James, Andrew F.
    PHYSIOLOGICAL REPORTS, 2015, 3 (01): : 1 - 10
12345